Interestingly, the inhibition of VEGFR/PDGFR by applying their kinase inhibitors sunitinib/SU11248 can accelerate metastatic tumor growth and decrease overall survival in mice, but cannot function as an anti-cancer strategy [40]. This evidence concerns the gene PDGFRB and metastatic neoplasm.